Corbett Schimming

638 total citations
22 papers, 392 citations indexed

About

Corbett Schimming is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology. According to data from OpenAlex, Corbett Schimming has authored 22 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Corbett Schimming's work include Dementia and Cognitive Impairment Research (14 papers), Schizophrenia research and treatment (6 papers) and Alzheimer's disease research and treatments (4 papers). Corbett Schimming is often cited by papers focused on Dementia and Cognitive Impairment Research (14 papers), Schizophrenia research and treatment (6 papers) and Alzheimer's disease research and treatments (4 papers). Corbett Schimming collaborates with scholars based in United States and Germany. Corbett Schimming's co-authors include Hillel Grossman, Mary Sano, Carolyn W. Zhu, Davangere P. Devanand, Jacobo Mintzer, Susan K. Schultz, Howard Andrews, Gregory H. Pelton, Bruce Levin and David L. Sultzer and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Journal of the American Geriatrics Society.

In The Last Decade

Corbett Schimming

19 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corbett Schimming United States 9 230 72 61 54 48 22 392
Nicholas Tilton United States 10 157 0.7× 76 1.1× 67 1.1× 43 0.8× 42 0.9× 16 499
Marc Dinkgreve Netherlands 9 209 0.9× 61 0.8× 50 0.8× 53 1.0× 61 1.3× 14 358
Mirjam Köhler Germany 10 277 1.2× 97 1.3× 101 1.7× 61 1.1× 83 1.7× 13 471
Kyung Phil Kwak South Korea 12 158 0.7× 81 1.1× 42 0.7× 36 0.7× 59 1.2× 30 389
Franziska Tebarth Germany 9 289 1.3× 132 1.8× 73 1.2× 64 1.2× 89 1.9× 9 473
Byeong Kil Yeon South Korea 8 219 1.0× 74 1.0× 48 0.8× 32 0.6× 28 0.6× 10 357
Linda Hewett United States 6 197 0.9× 68 0.9× 93 1.5× 35 0.6× 23 0.5× 8 350
Audra Wenzlow United States 6 206 0.9× 62 0.9× 98 1.6× 26 0.5× 37 0.8× 10 355
Elise Cornelis Belgium 8 209 0.9× 86 1.2× 34 0.6× 82 1.5× 36 0.8× 15 322
Hannareeta Öhman Finland 10 173 0.8× 52 0.7× 68 1.1× 67 1.2× 22 0.5× 18 323

Countries citing papers authored by Corbett Schimming

Since Specialization
Citations

This map shows the geographic impact of Corbett Schimming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corbett Schimming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corbett Schimming more than expected).

Fields of papers citing papers by Corbett Schimming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corbett Schimming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corbett Schimming. The network helps show where Corbett Schimming may publish in the future.

Co-authorship network of co-authors of Corbett Schimming

This figure shows the co-authorship network connecting the top 25 collaborators of Corbett Schimming. A scholar is included among the top collaborators of Corbett Schimming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corbett Schimming. Corbett Schimming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Carolyn W., Lon S. Schneider, Laili Soleimani, et al.. (2025). Understanding the Role of Neuropsychiatric Symptoms in Functional Decline in Alzheimer’s Disease. Journal of Neuropsychiatry. appineuropsych20250015–appineuropsych20250015.
2.
Zhu, Carolyn W., Gregory A. Elder, Laili Soleimani, et al.. (2024). Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline. American Journal of Geriatric Psychiatry. 32(12). 1402–1416. 6 indexed citations
3.
Zhu, Carolyn W., Margaret Sewell, Judith Neugroschl, et al.. (2023). Evaluating memory testing to distinguish dementia severity among White, Black, and Spanish‐speaking individuals in the Uniform Data Set (UDS). Alzheimer s & Dementia. 19(8). 3625–3634. 2 indexed citations
4.
Sano, Mary, Carolyn W. Zhu, Judith Neugroschl, et al.. (2022). Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition. American Journal of Geriatric Psychiatry. 30(11). 1198–1208. 7 indexed citations
5.
Schimming, Corbett, et al.. (2021). Effect of Social Determinants of Health on Cognition and Risk of Alzheimer Disease and Related Dementias. Clinical Therapeutics. 43(6). 922–929. 111 indexed citations
6.
Neugroschl, Judith, Carolyn W. Zhu, Margaret Sewell, et al.. (2021). Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-19. Alzheimer Disease & Associated Disorders. 35(2). 172–177. 3 indexed citations
7.
Grossman, Hillel, Mary Sano, Amy Aloysi, et al.. (2021). Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 13(1). e12169–e12169. 19 indexed citations
8.
Neugroschl, Judith, Carolyn W. Zhu, Amy Aloysi, et al.. (2020). Design Considerations for Mobile Health Applications Targeting Older Adults. Journal of Alzheimer s Disease. 79(1). 1–8. 36 indexed citations
9.
Sano, Mary, Carolyn W. Zhu, Hillel Grossman, & Corbett Schimming. (2017). Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data. Journal of the American Geriatrics Society. 65(10). 2198–2204. 19 indexed citations
10.
Zhu, Carolyn W., Hillel Grossman, Corbett Schimming, & Mary Sano. (2017). [P1–502]: NON‐AMNESTIC DEFICIT CHARACTERIZES THE COGNITIVE PROFILE IN DIABETES: RESULTS FROM NATIONAL ALZHEIMER'S COORDINATING CENTER'S UNIFORM DATA SET (NACC UDS). Alzheimer s & Dementia. 13(7S_Part_9). 2 indexed citations
11.
Devanand, Davangere P., Seonjoo Lee, Howard Andrews, et al.. (2016). O1‐13‐02: Prediction of Relapse Following Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: the Role of Hallucinations. Alzheimer s & Dementia. 12(7S_Part_4).
12.
Lee, Seonjoo, Howard Andrews, Gregory H. Pelton, et al.. (2016). Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer’s Disease: The Role of Hallucinations. American Journal of Psychiatry. 174(4). 362–369. 11 indexed citations
13.
Luo, Xiaodong, et al.. (2012). Cognition in Non-Demented Diabetic Older Adults. Current Aging Science. 5(2). 131–135. 25 indexed citations
14.
Devanand, Davangere P., Jacobo Mintzer, Susan K. Schultz, et al.. (2012). Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease. New England Journal of Medicine. 367(16). 1497–1507. 108 indexed citations
15.
Devanand, Davangere P., Jacobo Mintzer, Susan K. Schultz, et al.. (2011). The Antipsychotic Discontinuation in Alzheimer Disease Trial: Clinical Rationale and Study Design. American Journal of Geriatric Psychiatry. 20(4). 362–373. 8 indexed citations
16.
Kalapatapu, Raj K. & Corbett Schimming. (2009). Update on neuropsychiatric symptoms of dementia: antipsychotic use.. PubMed. 64(5). 10–8. 8 indexed citations
17.
Gandy, Sam & Corbett Schimming. (2008). Emerging Therapies for Alzheimer’s Disease. 4(2). 56–56.
18.
Schimming, Corbett & Philip D. Harvey. (2004). Disability Reduction in Elderly Patients with Schizophrenia. Journal of Psychiatric Practice. 10(5). 283–295. 4 indexed citations
19.
Franke, W.‐G., Klaus Zöphel, Gerhard Wunderlich, et al.. (2000). Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.. PubMed. 24(6). 524–30. 7 indexed citations
20.
Franke, W.‐G., Klaus Zöphel, Gerhard Wunderlich, et al.. (1999). Thyroid peroxidase (TPO) as a tumor marker in the follow-up of differentiated thyroid carcinomas with surgical and ablative radioiodine therapy. An assessment after evaluation.. PubMed. 19(4A). 2711–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas Tilton Breakdown of academic impact, for papers by Marc Dinkgreve Breakdown of academic impact, for papers by Mirjam Köhler Breakdown of academic impact, for papers by Kyung Phil Kwak Breakdown of academic impact, for papers by Franziska Tebarth Breakdown of academic impact, for papers by Byeong Kil Yeon Breakdown of academic impact, for papers by Linda Hewett Breakdown of academic impact, for papers by Audra Wenzlow Breakdown of academic impact, for papers by Elise Cornelis Breakdown of academic impact, for papers by Hannareeta Öhman
Rankless by CCL
2026